Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | AMGN | GILD | BMY | VRTX |
| Company | Swedish Orphan Biovitrum Ab | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 28.3000 | 260.00 | 92.19 | 56.34 | 407.57 |
| High | 28.3000 | 262.08 | 92.34 | 56.80 | 411.65 |
| Low | 28.3000 | 259.79 | 91.31 | 56.31 | 406.40 |
| Last | 28.3000 | 261.22 | 91.41 | 56.57 | 407.11 |
| Change | +0.6400 | +1.94 | -0.47 | +0.40 | +1.35 |
| % Change | +2.31% | +0.75% | -0.51% | +0.71% | +0.33% |
| Volume | 200 | 2,979,900 | 4,265,300 | 9,534,100 | 1,087,100 |
| 20-Day Average Volume | 655 | 3,698,280 | 6,556,190 | 11,264,185 | 1,880,990 |
| Previous Close | 27.6600 | 259.28 | 91.88 | 56.17 | 405.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.8200 | 266.45 | 92.39 | 57.24 | 434.39 |
| 20-Day Raw Stochastic | 51.68% | 29.66% | 41.09% | 32.42% | 29.67% |
| 20-Day Relative Strength | 52.47% | 33.85% | 50.06% | 49.27% | 36.06% |
| Weighted Alpha | N/A | -18.71 | +18.73 | +15.44 | -9.51 |
| Today's Opinion | N/A | 88% Sell | 72% Buy | 56% Buy | 72% Sell |
| Previous Opinion | N/A | 88% Sell | 88% Buy | 72% Buy | 72% Sell |
| Last Month's Opinion | N/A | 72% Sell | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.93% since 11/25/24 | -0.74% since 12/26/24 | -3.18% since 12/26/24 | -2.47% since 12/26/24 | -0.86% since 12/26/24 |
| Low | 27.6600 on 12/23/24 | 258.31 on 01/02/25 | 91.31 on 01/03/25 | 55.93 on 12/31/24 | 399.06 on 12/30/24 |
| High | 28.6203 on 12/10/24 | 263.58 on 01/02/25 | 94.38 on 12/27/24 | 58.38 on 12/27/24 | 411.65 on 01/03/25 |
| 1-Month | |||||
| %Chg | +1.29% since 12/02/24 | -6.14% since 12/03/24 | -1.17% since 12/03/24 | -3.61% since 12/03/24 | -10.91% since 12/03/24 |
| Low | 27.6600 on 12/23/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 28.6203 on 12/10/24 | 280.00 on 12/09/24 | 94.65 on 12/11/24 | 59.76 on 12/09/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -9.60% since 09/20/24 | -17.72% since 10/03/24 | +8.60% since 10/03/24 | +4.37% since 10/03/24 | -10.24% since 10/03/24 |
| Low | 27.2300 on 11/25/24 | 253.30 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 | 377.85 on 12/19/24 |
| High | 32.0100 on 10/25/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +6.75% since 07/02/24 | -15.57% since 07/03/24 | +37.27% since 07/03/24 | +41.21% since 07/03/24 | -13.43% since 07/03/24 |
| Low | 24.0750 on 08/05/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 32.2500 on 09/17/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,074,800 | 140,414,384 | 113,921,184 | 114,733,968 | 104,842,624 |
| Shares Outstanding, K | 356,000 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 2,086,200,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | 227,170,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | 508,280,000 | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | 20,920,000 | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.51 | 0.56 | 0.18 | 0.45 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 07/16/24 | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 02/13/25 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 40.68 | 13.49 | 20.74 | 48.54 | 0.00 |